SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries reports 47% fall in Q2 net profit

08 Nov 2012 Evaluate

Sun Pharmaceutical Industries has reported results for second ended September 30, 2012.

The company has reported 46.53% fall in its net profit at Rs 319.64 crore for the quarter as compared to Rs 597.74 crore for the same quarter in the previous year. However, total income of the company has increased by 40.45% at Rs 2663.88 crore for quarter under review as compared to Rs 1896.66 crore for the quarter ended September 30, 2011.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1874.15 26.85 (1.45%)
11-May-2026 10:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.15
Dr. Reddys Lab 1284.45
Cipla 1336.25
Zydus Lifesciences 938.15
Lupin 2251.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×